UnitedHealth Group stock gains as Optum Florida stake sale sharpens focus
Published on 09/09/2026 at 15:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UnitedHealth Group Inc. stock (ISIN US91324P1021) closed at USD 400.84 on the New York Stock Exchange on September 8, 2026, up about 0.9% from the prior session as investors digested a strategic stake sale in Optum Florida and a recent profit decline.
Optum Florida stake sale and strategy update
On September 9, 2026, UnitedHealth Group announced the sale of a stake in its Florida Optum Health operations to private equity firm TPG, aiming to sharpen its strategic focus and improve margins in the Optum segment after a recent profit decline, according to GuruFocus on September 9, 2026.
UnitedHealth Group senior leaders are scheduled to discuss the company’s strategy, market positions, recent results and outlook at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026 at 8:00 a.m. Eastern Time, with a live audio webcast available on the investor relations website, as noted by TipRanks on September 8, 2026.
Dividend profile and valuation signal
UnitedHealth offers a dividend yield of 2.26% with a payout ratio of 49% and a three-year dividend growth rate of 10.9%, indicating a steadily rising income stream backed by solid earnings capacity, according to GuruFocus on September 9, 2026.
From a valuation perspective, UnitedHealth Group’s stock is trading at USD 400.84 compared with a GF Value metric of USD 592.36, implying the shares are 32.3% undervalued on that framework and suggesting potential upside if the company delivers on its turnaround and margin improvement plans, as highlighted by GuruFocus on September 9, 2026.
UnitedHealth’s trailing price-earnings ratio stands at 25.79 times, very close to its five-year median P/E of 25.65 times, indicating that while the GF Value model points to undervaluation, the market is pricing the stock broadly in line with its historical earnings multiple, according to GuruFocus on September 9, 2026.
Analyst view and recent performance
The most recent analyst signal collected on UnitedHealth Group stock rates the shares as Buy with a price target of USD 512.00, reinforcing the view that the stock could appreciate further from current levels if execution remains strong, according to TipRanks on September 8, 2026.
TipRanks’ AI-based Spark Analyst currently scores UnitedHealth at 70 and classifies the shares as Outperform, citing strong and improving cash generation and durable revenue growth, balanced against significant margin compression and some balance-sheet data reliability concerns, according to TipRanks on September 8, 2026.
Per recent trading data, UnitedHealth Group stock most recently changed hands around USD 397.14 in New York trading on September 8, 2026, with one-year price performance showing a gain of 29.3% and a year-to-date increase of 21.9%, underlining strong medium-term returns for shareholders, according to Ad-hoc-news on September 9, 2026.
Stock price and market context
UnitedHealth Group stock closed at USD 400.84 on the New York Stock Exchange on September 8, 2026, with an intraday trading range between roughly USD 395.20 and USD 402.23 and volume in the low single-digit millions of shares, per market data for that session.
Key data on UnitedHealth Group stock
- Company: UnitedHealth Group Inc.
- ISIN: US91324P1021
- Ticker: UNH
- Trading venue: NYSE
- Price (as of September 8, 2026): 400.84 USD
- Market capitalization: [value] USD (as of September 8, 2026)
- Sector / Industry: Health Care / Managed Health Care
- Index membership: S&P 500
